[cnbc 3000029000]
Clinical trials for approval of UNIS’s syringe are expected to start in Q4 2011, with Mad Money host Jim Cramer, and Alan Shortall, Unilife’s CEO.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Video © and provided by CNBC.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Be the first to comment